musicaiz: A Python Library for Symbolic Music Generation, Analysis and Visualization

In this article, we present musicaiz, an object-oriented library for analyzing, generating and evaluating symbolic music. The submodules of the package allow the user to create symbolic music data from scratch, build algorithms to analyze symbolic music, encode MIDI data as tokens to train deep learning sequence models, modify existing music data and evaluate music generation systems. The evaluation submodule builds on previous work to objectively measure music generation systems and to be able to reproduce the results of music generation models. The library is publicly available online. We encourage the community to contribute and provide feedback

Music Boundary Detection using Convolutional Neural Networks: A comparative analysis of combined input features

The analysis of the structure of musical pieces is a task that remains a challenge for Artificial Intelligence, especially in the field of Deep Learning. It requires prior identification of structural boundaries of the music pieces. This structural boundary analysis has recently been studied with unsupervised methods and \textit{end-to-end} techniques such as Convolutional Neural Networks (CNN) using Mel-Scaled Log-magnitude Spectograms features (MLS), Self-Similarity Matrices (SSM) or Self-Similarity Lag Matrices (SSLM) as inputs and trained with human annotations. Several studies have been published divided into unsupervised and \textit{end-to-end} methods in which pre-processing is done in different ways, using different distance metrics and audio characteristics, so a generalized pre-processing method to compute model inputs is missing. The objective of this work is to establish a general method of pre-processing these inputs by comparing the inputs calculated from different pooling strategies, distance metrics and audio characteristics, also taking into account the computing time to obtain them. We also establish the most effective combination of inputs to be delivered to the CNN in order to establish the most efficient way to extract the limits of the structure of the music pieces. With an adequate combination of input matrices and pooling strategies we obtain a measurement accuracy $F_1$ of 0.411 that outperforms the current one obtained under the same conditions

Direction of Arrival Estimation of Sound Sources Using Icosahedral CNNs

In this paper, we present a new model for Direction of Arrival (DOA) estimation of sound sources based on an Icosahedral Convolutional Neural Network (CNN) applied over SRP-PHAT power maps computed from the signals received by a microphone array. This icosahedral CNN is equivariant to the 60 rotational symmetries of the icosahedron, which represent a good approximation of the continuous space of spherical rotations, and can be implemented using standard 2D convolutional layers, having a lower computational cost than most of the spherical CNNs. In addition, instead of using fully connected layers after the icosahedral convolutions, we propose a new soft-argmax function that can be seen as a differentiable version of the argmax function and allows us to solve the DOA estimation as a regression problem interpreting the output of the convolutional layers as a probability distribution. We prove that using models that fit the equivariances of the problem allows us to outperform other state-of-the-art models with a lower computational cost and more robustness, obtaining root mean square localization errors lower than 10{\deg} even in scenarios with a reverberation time $T_{60}$ of 1.5 s.Comment: Submitted to IEEE/ACM Transactions on Audio Speech and Language Processing. The code to reproduce this work can be found in our GitHub repository: https://github.com/DavidDiazGuerra/icoDO

IRAS 21391+5802: The Molecular Outflow and its Exciting Source

We present centimeter and millimeter observations of gas and dust around IRAS 21391+5802, an intermediate-mass source embedded in the core of IC 1396N. Continuum observations from 3.6 cm to 1.2 mm are used to study the embedded objects and overall distribution of the dust, while molecular line observations of CO, CS, and CH3OH are used to probe the structure and chemistry of the outflows in the region. The continuum emission at centimeter and millimeter wavelengths has been resolved into three sources separated about 15 arcsec from each other, and with one of them, BIMA 2, associated with IRAS 21391+5802. The dust emission around this source shows a very extended envelope, which accounts for most of the circumstellar mass of 5.1 Msun. This source is powering a strong molecular outflow, elongated in the E--W direction, which presents a complex structure and kinematics. While at high outflow velocities the outflow is clearly bipolar, at low outflow velocities the blueshifted and redshifted emission are highly overlapping, and the strongest emission shows a V-shaped morphology. The outflow as traced by CS and CH3OH exhibits two well differentiated and clumpy lobes, with two prominent northern blueshifted and redshifted clumps. The curved shape of the clumps and the spectral shape at these positions are consistent with shocked material. In addition, CS and CH3OH are strongly enhanced toward these positions with respect to typical quiescent material abundances in other star-forming regions.Comment: 41 pages, including 11 figures, accepted for publication in ApJ (July 1); available at http://www.am.ub.es/~robert/Papers.html#las

A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: The Bolivian Chagas Platform

BACKGROUND: Bolivia has the highest prevalence of Chagas disease (CD) in the world (6.1%), with more than 607,186 people with Trypanosoma cruzi infection, most of them adults. In Bolivia CD has been declared a national priority. In 2009, the Chagas National Program (ChNP) had neither a protocol nor a clear directive for diagnosis and treatment of adults. Although programs had been implemented for congenital transmission and for acute cases, adults remained uncovered. Moreover, health professionals were not aware of treatment recommendations aimed at this population, and research on CD was limited; it was difficult to increase awareness of the disease, understand the challenges it presented, and adapt strategies to cope with it. Simultaneously, migratory flows that led Bolivian patients with CD to Spain and other European countries forced medical staff to look for solutions to an emerging problem. INTERVENTION: In this context, thanks to a Spanish international cooperation collaboration, the Bolivian platform for the comprehensive care of adults with CD was created in 2009. Based on the establishment of a vertical care system under the umbrella of ChNP general guidelines, six centres specialized in CD management were established in different epidemiological contexts. A common database, standardized clinical forms, a and a protocolized attention to adults patients, together with training activities for health professionals were essential for the model success. With the collaboration and knowledge transfer activities between endemic and non-endemic countries, the platform aims to provide care, train health professionals, and create the basis for a future expansion to the National Health System of a proven model of care for adults with CD. RESULTS: From 2010 to 2015, a total of 26,227 patients were attended by the Platform, 69% (18,316) were diagnosed with T. cruzi, 8,567 initiated anti-parasitic treatment, more than 1,616 health professionals were trained, and more than ten research projects developed. The project helped to increase the number of adults with CD diagnosed and treated, produce evidence-based clinical practice guidelines, and bring about changes in policy that will increase access to comprehensive care among adults with CD. The ChNP is now studying the Platform's health care model to adapt and implement it nationwide. CONCLUSIONS: This strategy provides a solution to unmet demands in the care of patients with CD, improving access to diagnosis and treatment. Further scaling up of diagnosis and treatment will be based on the expansion of the model of care to the NHS structures. Its sustainability will be ensured as it will build on existing local resources in Bolivia. Still human trained resources are scarce and the high staff turnover in Bolivia is a limitation of the model. Nevertheless, in a preliminary two-years-experience of scaling up this model, this limitations have been locally solved together with the health local authorities

Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex

Targeting the dysregulated BRaf-MEK-ERK pathway in cancer has increasingly emerged in clinical trial design. Despite clinical responses in specific cancers using inhibitors targeting BRaf and MEK, resistance develops often involving non-genomic adaptive bypass mechanisms. Inhibition of MEK1/2 by trametinib in triple negative breast cancer (TNBC) patients induced dramatic transcriptional responses, including upregulation of receptor tyrosine kinases (RTKs) comparing tumor samples before and after one week of treatment. In preclinical models MEK inhibition induced genome-wide enhancer formation involving the seeding of BRD4, MED1, H3K27 acetylation and p300 that drives transcriptional adaptation. Inhibition of P-TEFb associated proteins BRD4 and CBP/p300 arrested enhancer seeding and RTK upregulation. BRD4 bromodomain inhibitors overcame trametinib resistance, producing sustained growth inhibition in cells, xenografts and syngeneic mouse TNBC models. Pharmacological targeting of P-TEFb members in conjunction with MEK inhibition by trametinib is an effective strategy to durably inhibit epigenomic remodeling required for adaptive resistance

Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: the ESCARVAL-RISK study

The potential impact of targeting different components of an adverse lipid profile in populations with multiple cardiovascular risk factors is not completely clear. This study aims to assess the association between different components of the standard lipid profile with all cause mortality and hospitalization due to cardiovascular events in a high-risk population. Methods This prospective registry included high risk adults over 30 years old free of cardiovascular disease (2008±2012). Diagnosis of hypertension, dyslipidemia or diabetes mellitus was inclusion criterion. Lipid biomarkers were evaluated. Primary endpoints were all-cause mortality and hospital admission due to coronary heart disease or stroke. We estimated adjusted rate ratios (aRR), absolute risk differences and population attributable risk associated with adverse lipid profiles. Results 51,462 subjects were included with a mean age of 62.6 years (47.6% men). During an average follow-up of 3.2 years, 919 deaths, 1666 hospitalizations for coronary heart disease and 1510 hospitalizations for stroke were recorded. The parameters that showed an increased rate for total mortality, coronary heart disease and stroke hospitalization were, respectively, low HDL-Cholesterol: aRR 1.25, 1.29 and 1.23; high Total/HDL-Cholesterol: aRR 1.22, 1.38 and 1.25; and high Triglycerides/HDL-Cholesterol: aRR 1.21, 1.30, 1.09. The parameters that showed highest population attributable risk (%) were, respectively, low HDL-Cholesterol: 7.70, 11.42, 8.40; high Total/HDL-Cholesterol: 6.55, 12.47, 8.73; and high Triglycerides/ HDL-Cholesterol: 8.94, 15.09, 6.92. Conclusions In a population with cardiovascular risk factors, HDL-cholesterol, Total/HDL-cholesterol and triglycerides/HDL-cholesterol ratios were associated with a higher population attributable risk for cardiovascular disease compared to other common biomarkers

Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial

<p>Abstract</p> <p>Background</p> <p>Although benzodiazepines are effective, long-term use is not recommended because of potential adverse effects; the risks of tolerance and dependence; and an increased risk of hip fractures, motor vehicle accidents, and memory impairment. The estimated prevalence of long-term benzodiazepine use in the general population is about 2,2 to 2,6%, is higher in women and increases steadily with age. Interventions performed by General Practitioners may help patients to discontinue long-term benzodiazepine use. We have designed a trial to evaluate the effectiveness and safety of two brief general practitioner-provided interventions, based on gradual dose reduction, and will compare the effectiveness of these interventions with that of routine clinical practice.</p> <p>Methods/Design</p> <p>In a three-arm cluster randomized controlled trial, general practitioners will be randomly allocated to: a) a group in which the first patient visit will feature a structured interview, followed by visits every 2-3 weeks to the end of dose reduction; b) a group in which the first patient visit will feature a structured interview plus delivery of written instructions to self-reduce benzodiazepine dose, or c) routine care. Using a computerized pharmaceutical prescription database, 495 patients, aged 18-80 years, taking benzodiazepine for at least 6 months, will be recruited in primary care health districts of three regions of Spain (the Balearic Islands, Catalonia, and Valencia). The primary outcome will be benzodiazepine use at 12 months. The secondary outcomes will include measurements of anxiety and depression symptoms, benzodiazepine dependence, quality of sleep, and alcohol consumption.</p> <p>Discussion</p> <p>Although some interventions have been shown to be effective in reducing benzodiazepine consumption by long-term users, the clinical relevance of such interventions is limited by their complexity. This randomized trial will compare the effectiveness and safety of two complex stepped care interventions with that of routine care in a study with sufficient statistical power to detect clinically relevant differences.</p> <p>Trial Registration</p> <p>Current Controlled Trials: <a href="http://www.controlled-trials.com/ISRCTN13024375">ISRCTN13024375</a></p